These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6995308)

  • 1. Analysis of outer membrane components of Escherichia coli ML308 225 and of a serum-resistant mutant.
    Tee GL; Scott GK
    Infect Immun; 1980 May; 28(2):387-92. PubMed ID: 6995308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen.
    Goldman RC; Joiner K; Leive L
    J Bacteriol; 1984 Sep; 159(3):877-82. PubMed ID: 6207166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of purified lipopolysaccharide on the bactericidal reaction of human serum complement.
    Allen RJ; Scott GK
    J Gen Microbiol; 1980 Mar; 117(1):65-72. PubMed ID: 6993628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide.
    Joiner KA; Schmetz MA; Goldman RC; Leive L; Frank MM
    Infect Immun; 1984 Jul; 45(1):113-7. PubMed ID: 6203836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable insertion of C5b-9 complement complexes into the outer membrane of serum treated, susceptible Escherichia coli cells as a prerequisite for killing.
    Kroll HP; Voigt WH; Taylor PW
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec; 258(2-3):316-26. PubMed ID: 6397947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human serum complement requirements for bacterial killing and protoplast lysis of Escherichia coli ML308 225.
    Allen RJ; Scott GK
    J Gen Microbiol; 1981 Mar; 123(1):179-81. PubMed ID: 7033454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superoxide dismutase protects Escherichia coli against killing by human serum.
    McManus DC; Josephy PD
    Arch Biochem Biophys; 1995 Feb; 317(1):57-61. PubMed ID: 7872803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane changes induced by exposure of Escherichia coli to human serum.
    Kroll HP; Bhakdi S; Taylor PW
    Infect Immun; 1983 Dec; 42(3):1055-66. PubMed ID: 6358036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of human complement proteins with serum-sensitive and serum-resistant strains of Escherichia coli.
    Taylor PW; Kroll HP
    Mol Immunol; 1984 Jul; 21(7):609-20. PubMed ID: 6379418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetical studies of serum resistance in Escherichia coli.
    Taylor PW
    J Gen Microbiol; 1975 Jul; 89(1):57-66. PubMed ID: 1097595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
    Horwitz MA; Silverstein SC
    J Clin Invest; 1980 Jan; 65(1):82-94. PubMed ID: 6985617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli.
    Madsen LM; Inada M; Weiss J
    Infect Immun; 1996 Jul; 64(7):2425-30. PubMed ID: 8698462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidoglycan Association of Murein Lipoprotein Is Required for KpsD-Dependent Group 2 Capsular Polysaccharide Expression and Serum Resistance in a Uropathogenic
    Diao J; Bouwman C; Yan D; Kang J; Katakam AK; Liu P; Pantua H; Abbas AR; Nickerson NN; Austin C; Reichelt M; Sandoval W; Xu M; Whitfield C; Kapadia SB
    mBio; 2017 May; 8(3):. PubMed ID: 28536290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
    Tesh VL; Duncan RL; Morrison DC
    J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular composition of the outer membrane of Escherichia coli and the importance of protein-lipopolysaccharide interactions.
    Gmeiner J; Schlecht S
    Arch Microbiol; 1980 Sep; 127(2):81-6. PubMed ID: 7000027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis and turnover of outer-membrane proteins in Escherichia coli ML308-225.
    Allen RJ; Scott GK
    Biochem J; 1979 Aug; 182(2):407-12. PubMed ID: 389236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outer membrane proteins of Escherichia coli. IV. Differences in outer membrane proteins due to strain and cultural differences.
    Schnaitman CA
    J Bacteriol; 1974 May; 118(2):454-64. PubMed ID: 4597444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane biogenesis in Escherichia coli: effects of a secA mutation.
    de Cock H; Meeldijk J; Overduin P; Verkleij A; Tommassen J
    Biochim Biophys Acta; 1989 Nov; 985(3):313-9. PubMed ID: 2679887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and properties of complement-resistant strains of Escherichia coli K-12.
    Akiyama Y; Inoue K
    Infect Immun; 1977 Nov; 18(2):446-53. PubMed ID: 336545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.